intro to leukaemia Flashcards

1
Q

What is leukaemia?

A

Malignant disorders of haemtopoietic stem cells characteristically associated with increased number of white cells in the bone marrow and/or peipheral blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What three lineages are all blood cells divided into?

A

Red blood cell/ erythrocytes - oxygen carrying cells, released into blood

Lymphocytes, derived from common lymphoid progenitors - B cells, T cells and natural killer cells

Cells of myeloid lineage – granulocytes, karyocytes, macrophages. Derived from common myeloid progenitors, involved in innate immune system and blood clotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What two types of progenitor cells are there?

A

Undifferentiated progenitor cells (multipotent): can’t tell difference between them morphologically, don’t show characteristics of mature cells

  • give rise to two different lineages

Progenitor cells - committed (unipotentt): committed to what they’ll become

  • can only give rise to one type of blood cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What can drive progenitors or HSCs to pre-leukemic stage?

A

Oncogenic transcription factors.

Secondary mutation required to induce full blown leukaemia through increased survival and proliferation.

malignant cells derived from single mutant stem cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the incidence of leukaemia?

A

Related to AIDS, highest incidence in older people.

in UK 2013-2015, 4/10 new cases were in people 75+

rates higher in males than females in older age groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the presentation of leukaemia?

A

Varies between types.

Symptoms:

Abnormal bruising commonest

Repeating abnormal infection due to absence of normal white cells and immune power to fight disease

Sometimes anaemia due to reduced production of RBC – symptoms like fatigue, shortness of breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is leukaemia diagnosed?

A

Extract biopsy from bone marrow,

  • Blast mature cells
  • Light coloured RBC

Peripheral blood blasts test (PB) to check for presence of blasts and cytopenia. >30% blasts are suspected of acute leukaemia

Bone marrow test/biopsy (BM): taken from pelvic bone and results compared with PB

Lumbar puncture: to determine if the leukaemia has spread to cerebral spinal fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

After estabilishing leukaemia it must be characterised

What is used to characterise leukaemia?

A

Cell surface markers

Cytomorphology of cells

Using next gen seq to find mutations that may have caused leukaemia

Flow cytometry

Immunophenotyping

Fluorescence in situ hybridisation

Methods done to try to detect different cellular markers and detect mutations which are characteristic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the genetic risk factors of leukaemia?

A

Gene mutations involving oncogenes (Activation) or/and tumour suppressors (inactivation)

  • Involving genes common to other malignancies (tp53- Li-Fraumeni syndrome, NF1-Neurofibromatosis) or specific to leukaemia

Chromosome aberrations

  • Translocations (e.g BCR-ABL in CML) give rise to new chromosome, triggered factor of 95% of chronic myeloid leukaemia’s
  • All leukaemia’s can be associated with numerical disorders (e.g trisomy 21-Down syndrome)

Inherited immune system problems (e.g Ataxia-telangiectasia, Wiskott-Aldrich syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the environmental risk factors of leukaemia?

A

Radiation exposure

  • Acute radiation accidents
  • Atomic bomb survivors

Exposure to chemicals and chemotherapy

  • Cancer chemotherapy with alkylating agents e.g busulphan
  • Industrial exposure to benzene

Immune system suppression

  • e.g after organ transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the lifestyle releated risk factors of leukamia?

A

Smoking

Drinking

Excessive exposure to sun

Overweight

other risk factors:

Exposure to electromagnetic fields

infections early in life

nuclae power stations

foetal exposure to hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classification of leukaemia

What is acute leukaemia?

A

Rapid onset and short but severe course

Undifferentiated leukaemia, characterised by uncontrolled clonal and accumulation of immature white blood cells (blast)

Bone marrow and blood sample has high number of blast cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is chronic leukaemia?

A

Persisting over a long time.

Differentiated leukaemia.

Characterised by uncontrolled clonal and accumulation of mature white blood cells (-cyte)

Affects cells that have already differentiated, unipotent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between acute and chronic leukaemia?

A

Age: children in acute, elderly in chronic

Onset: sudden, insidious

Duration: weeks to months, years

WBC: variable, high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two types of acute leukaemia?

A

Acute lymphoblastic leukaemia (ALL)

Acute myeloblastic leukaemia (AML)

  • commonest type of cancer in childood
  • 31% of total cancers in children, 75% cases ALL, 20% AML
  • characterised by large numbers of lymphoblasts or myeloid blasts in bm and blood
  • arresst of mature process, breaks balance between proliferation and cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the symptoms of acute leukaemia?

A

Due to BM suppression:

Thrombocytopenia (low platelets): purpura (bruising), epistaxis (nosebleed), bleeding from gums. Are the most common symptoms.

Neutropenia (low neutrophils): recurrent infections and fever

Anaemia: lassitude, weakness, tiredness, shortness of breath

17
Q

What is the origin of chronic lymphocytic leukaemia?

What are the symptoms?

What is treatment?

A
  1. Large numbers of clonal lymphocytes in BM and blood.

2.

Recurrent infections due to neutropenia

Suppression of normal lymphocyte function

Anaemia

Thrombocytopenia

Lymph node enlargement

Hepatosplenomegaly

3.

Regularly chemotherapy to reduce cell numbers

18
Q

What is the origin of Chronic myeloid/granulocytic leukaemia?

Symptoms

Treatment

A
  1. Large number of mature myeloid white blood cells
  2. Asymptomatic, discovered through blood tests - high white blood cell count (neutrophilia) and philadelphia chromosome
  3. targeted therapy , imatinib.
19
Q

What is BCR?

A

Encodes a protein that needs to be continously active.

Its promoter is strong and active, promotes permanent transcription of the gene.

20
Q

What is ABL?

A

Encodes a protein tyrosine kinase whose activity is tightly regulated (auto-inhibition)

A proto-oncogene.

Tyrosine kinase needs ATP molecules in order to phosphorylate its substrates.

21
Q

How does the BCR-ABL oncogene come about?

A

Translocation brings ABL gene under transcriptional regulation of BCR promoter.

Promoter controls transcription of ABL gene

therefore BCR-ABL protein has constitutive (unregulated) protein tyrosine kinase activity

22
Q

What does unregulated BCR-ABL activity cause?

A

Tyrosine kinase activity causes:

  • Proliferation of progenitor cells in the absence of growth factors
  • Decreased apoptosis
  • Decreased adhesion to bone marrow stroma

Triggers leukaemia

23
Q

How is FISH used when diagnosising chronic myeloid leukaemia?

A

95% of CML have detectable Ph’ chromosome

FISH checks for Ph’ chromosome

Use of two probes, red = ABL gene, green = BCR gene

Ph’ chromosome, two chromosomes are fused, see both colours

also used in detection of minimal residual disease

24
Q

How does Imatinib work?

A

Small molecule inhibitor, targets ABL-CML treatment

Inhibits continuously active tyrosine kinase activity of fusion protein

ABL gene contributes with tyrosine kianse activity, needs ATP to phosphorylate substrates to make it active

Imatinib competes with ATP, binds to BCR-ABL, preventing ATP from binding, can’t phosphorylate tyrosine

Oncogene not able to activate downstreamt pathways

25
Q
A